key: cord-0936208-z8arh6yd authors: Hall, Kelli Stidham; Samari, Goleen; Garbers, Samantha; Casey, Sara E; Diallo, Dazon Dixon; Orcutt, Miriam; Moresky, Rachel T; Martinez, Micaela Elvira; McGovern, Terry title: Centring sexual and reproductive health and justice in the global COVID-19 response date: 2020-04-09 journal: Lancet DOI: 10.1016/s0140-6736(20)30801-1 sha: 6afc2fb4376a939c5e263c98a014303e9cb45273 doc_id: 936208 cord_uid: z8arh6yd nan groups are likely to carry a heavier burden of what will be the devastating downstream economic and social consequences of this pandemic. 2 A sexual and reproductive health and justice framework-one that centres human rights, acknowledges intersecting injustices, recognises power structures, and unites across identities-is essential for monitoring and addressing the inequitable gender, health, and social effects of COVID19. The complex interplay between biological and behav ioural risk factors needs to be recognised during the COVID19 pandemic. It is not yet known whether the higher COVID19 case fatality rates reported in men compared with women in China, South Korea, and Italy 3 to date are attributed to sexspecific biological susceptibility, variations in preexisting comorbidities, behavioural risk factors, or some combination of these factors. 4, 5 In terms of behavioural risk factors, women's risk of contracting COVID19 may be higher than men's risk as women are frontline providers, comprising 70% of the global health and social care workforce, and they do three times as much unpaid care work at home as men. 2, 6 Moreover, pregnant women could be at risk of pregnancyrelated complications during the COVID19 pandemic. 7 Severe acute respiratory syndrome and Middle East respiratory syndrome were associated with increased risk of pregnancyrelated morbidity and mortality, 7 but data on COVID19 are scarce. 8 In China, among nine women in their third trimester with COVID19, clinical outcomes were similar to non pregnant adults. 4 Yet another study of 33 neonates born to mothers with COVID19 identified intrauterine vertical transmission of COVID19 in three neonates. 9 However, studies to date have been based on third trimester cases and viral infections during pregnancy are typically most severe during the first 20 weeks of gestation. 10 Disruption of services and diversion of resources away from essential sexual and reproductive health care because of prioritising the COVID19 response are expected to increase risks of maternal and child morbidity and mortality. 6, 7 Globally, there are anticipated shortages of contraception. 11 Sexual and reproductive health providers and clinics, which are the primary care providers and safety net for women of reproductive aged, youth, those uninsured for health care, and people on low incomes in many countries including in the USA, may also be deemed nonessential and diverted to respond to COVID19. 6 Past humanitarian crises have shown that reduced access to family planning, abortion, antenatal, HIV, genderbased violence, and mental health care services results in increased rates and sequelae from unintended pregnancies, unsafe abortions, sexually transmitted infections (STIs), pregnancy complications, miscarriage, posttraumatic stress disorder, depression, suicide, intimate partner violence, and maternal and infant mortality. 1, 12 Additionally, systemic racism, dis crimi nation, and stigma are likely to further compound logistical barriers to accessing sexual and reproductive health care for women and marginalised groups. Restrictive global policies that target vulnerable populations will exacerbate sexual and reproductive health and justice inequities. The US administration's Protecting Life in Global Health Assistance (PLGHA) policy is of grave concern. The PLGHA expanded the Global Gag Rule (the Mexico City policy), which blocks US global health assistance to foreign nongovernmental organisations that provide, counsel, refer, or advocate for abortion services. Three crucial impacts of the PLGHA include decreased stakeholder coordination and chilling of sexual and reproductive health and rights discussions; reduced access to family planning, with increases in unintended pregnancy and induced abortion; and negative outcomes beyond sexual and reproductive health, including weakened health systems functioning. 13 Migration policies of deterrence, including closures at US and European borders, force women to live in informal settlements or conditions of poverty for long periods of time, often without basic sanitation and hygiene or access to health care during antenatal and postnatal periods. Only when public health responses to COVID19 leverage intersectional, human rights centred frame works, transdisciplinary sciencedriven theories and methods, 14 and communitydriven approaches, will they sufficiently prevent complex health and social adversities for women, girls, and vulnerable populations. The way forwards will not be easy. Even rigorous implementation of sciencedriven approaches might not match the pace of COVID19 threats in the face of reduced human capacity, shortages of drugs and supplies, and increased demands on already strained sexual and reproductive health services. For clinical services and programmes, additional resources must be directed to, not diverted from, the sexual and reproductive health workforce so that effective, evidencebased approaches are deployed. Olivier Douliery/Getty Images Previous humanitarian crises have shown the crucial role of contraception and medication abortion for the prevention of unintended pregnancy and maternal mortality. 15 Resources also need to ensure access to skilled health workers for deliveries and emergency obstetric care. Telemedicine can be used to provide access to services for medication abortion, contraception, and expedited partner therapy for STI prevention, as well as traumainformed care for managing genderbased violence, posttraumatic stress disorder, depression, and suicide. 16, 17 Sexdisaggregated mortality and morbidity surveillance data should be a priority in COVID19 research. 3, 5 Plans must prioritise protections for participants but account for gender perspectives, lived experiences, and outcomes in research design, intervention, evaluation, interpre tation, and dissemination. Immediate research priorities focused on identifying the pathophysiology of the disease and the development of vaccines and therapeutics should give explicit attention to sex differences in viral transmission and disease progression, biological, social, and environmental risks by gender, and safety of vaccines and drugs for pregnant and lactating women. 18 All these efforts must be community driven. Recognition of inequitable power structures, distri bution of resources, and a collaborative approach dictates the way forward. Advocates must continue to fight the exploitation of the COVID19 crisis to further an agenda that restricts access to essential sexual and reproductive health services, particularly abortion, and targets immigrants and adolescents. A sexual and reproductive health and justice policy agenda must be at the heart of the COVID19 response. The response must ensure that universal health coverage includes pregnant women, adolescents, and marginalised groups and must designate sexual and reproductive health, family planning, and community health centres as essential health providers, reallocating resources accordingly. Policy makers should scale up telemedicine for needed, evidencebased care for women and girls, including sexual and reproductive health care. Finally, the response must eliminate legal and policy restrictions to sexual and reproductive health service provision and reverse the PLGHA and Global Gag Rule to ensure comprehensive sexual and reproductive health care for women and girls around the world. Reproductive health of waraffected populations: what do we know? COVID19: the gendered impacts of the outbreak Global Health 5050. Sex, gender and COVID19 2020 Clinical characteristics and intrauterine vertical transmission potential of COVID19 infection in nine pregnant women: a retrospective review of medical records Sex, gender and COVID19: disaggregated data and health disparities COVID19: a gender lens protecting sexual and reproductive health and rights and promoting gender equality Coronavirus sisease 2019 (COVID19) and pregnancy: what obstetricians need to know Information for healthcare providers: COVID19 and pregnant women Neonatal earlyonset infection with SARSCoV2 in 33 neonates born to mothers with COVID19 in Wuhan, China What are the risks of COVID19 infection in pregnant women? Opinion: how will COVID19 affect global access to contraceptives-and what can we do about it? Devex Natality decline and miscarriages associated with the 1918 influenza pandemic: the Scandinavian and United States experiences Preventing and reducing the harm of the protecting life in global health assistance policy in global public health. Policy statements Modernising epidemic science: enabling patient centred research during epidemics Why don't humanitarian organizations provide safe abortion services? Medication abortion provided through telemedicine in four US states Effectiveness of telemedicine: a systematic review of reviews American College of Obstetricians and Gynecologists. Novel coronavirus 2019 (COVID19) practice advisory We declare no competing interests.